357 related articles for article (PubMed ID: 18034421)
1. Selective silencing of DNA-specific B lymphocytes delays lupus activity in MRL/lpr mice.
Tchorbanov AI; Voynova EN; Mihaylova NM; Todorov TA; Nikolova M; Yomtova VM; Chiang BL; Vassilev TL
Eur J Immunol; 2007 Dec; 37(12):3587-96. PubMed ID: 18034421
[TBL] [Abstract][Full Text] [Related]
2. Simultaneous engagement of FcgammaIIb and CD22 inhibitory receptors silences targeted B cells and suppresses autoimmune disease activity.
Mihaylova N; Voynova E; Tchorbanov A; Dolashka-Angelova P; Bayry J; Devreese B; Kaveri S; Vassilev T
Mol Immunol; 2009 Nov; 47(1):123-30. PubMed ID: 19243823
[TBL] [Abstract][Full Text] [Related]
3. Selective silencing of disease-associated B-lymphocytes by chimeric molecules targeting their Fc gamma IIb receptor.
Mihaylova N; Voynova E; Tchorbanov A; Nikolova M; Michova A; Todorov T; Srebreva L; Taskov H; Vassilev T
Int Immunol; 2008 Feb; 20(2):165-75. PubMed ID: 18156625
[TBL] [Abstract][Full Text] [Related]
4. Target silencing of disease-associated B-lymphocytes by chimeric molecules in SCID model of pristane-induced autoimmunity.
Dimitrova I; Gesheva V; Nikolova K; Mihaylova N; Todorov T; Nikolova M; Tchorbanov A
Lupus; 2010 Oct; 19(11):1261-71. PubMed ID: 20530521
[TBL] [Abstract][Full Text] [Related]
5. Selective silencing of autoreactive B lymphocytes-Following the Nature's way.
Nikolova KA; Mihaylova NM; Voynova EN; Tchorbanov AI; Voll RE; Vassilev TL
Autoimmun Rev; 2010 Sep; 9(11):775-9. PubMed ID: 20601201
[TBL] [Abstract][Full Text] [Related]
6. Effects of FTY720 in MRL-lpr/lpr mice: therapeutic potential in systemic lupus erythematosus.
Okazaki H; Hirata D; Kamimura T; Sato H; Iwamoto M; Yoshio T; Masuyama J; Fujimura A; Kobayashi E; Kano S; Minota S
J Rheumatol; 2002 Apr; 29(4):707-16. PubMed ID: 11950011
[TBL] [Abstract][Full Text] [Related]
7. An antibody-based construct carrying DNA-mimotope and targeting CR1(CD35) selectively suppresses human autoreactive B-lymphocytes.
Voynova E; Tchorbanov A; Prechl J; Nikolova M; Baleva M; Erdei A; Vassilev T
Immunol Lett; 2008 Mar; 116(2):168-73. PubMed ID: 18262286
[TBL] [Abstract][Full Text] [Related]
8. Clear suppression of Th1 responses but marginal amelioration of autoimmune manifestations by IL-12p40 transgene in MRL-FAS(lprcg)/FAS(lprcg) mice.
Yasuda T; Yoshimoto T; Tsubura A; Matsuzawa A
Cell Immunol; 2001 Jun; 210(2):77-86. PubMed ID: 11520074
[TBL] [Abstract][Full Text] [Related]
9. Suppression of dsDNA-specific B lymphocytes reduces disease symptoms in SCID model of mouse lupus.
Gesheva V; Kerekov N; Nikolova K; Mihaylova N; Todorov T; Nikolova M; Tchorbanov A
Autoimmunity; 2014 May; 47(3):162-72. PubMed ID: 24502777
[TBL] [Abstract][Full Text] [Related]
10. [Effects of HS1-associated protein X-1 on the lupus activities: experiment with MRL/lpr lupus-like mice].
Zhai ZF; Zhou CL; Zhong BY; Ao JH; Hao F
Zhonghua Yi Xue Za Zhi; 2008 Feb; 88(6):406-10. PubMed ID: 18581896
[TBL] [Abstract][Full Text] [Related]
11. Re-establishing tolerance to DNA in humanized and murine models of SLE.
Nikolova K; Mihaylova N; Voynova E; Kerekov N; Gesheva V; Prechl J; Nikolova M; Tchorbanov A
Autoimmun Rev; 2010 May; 9(7):499-502. PubMed ID: 20149897
[TBL] [Abstract][Full Text] [Related]
12. [Functional analysis of an autoantigen reactive B cell clone derived from MRL/MP-lpr/lpr mice].
Kobayashi K; Hamano T; Kakishita E
Ryumachi; 1996 Dec; 36(6):844-55. PubMed ID: 9122824
[TBL] [Abstract][Full Text] [Related]
13. Autoimmunization in murine graft-vs-host disease. I. Selective production of antibodies to histones and DNA.
Portanova JP; Claman HN; Kotzin BL
J Immunol; 1985 Dec; 135(6):3850-6. PubMed ID: 3877758
[TBL] [Abstract][Full Text] [Related]
14. Critical role of TLR2 and TLR4 in autoantibody production and glomerulonephritis in lpr mutation-induced mouse lupus.
Lartigue A; Colliou N; Calbo S; François A; Jacquot S; Arnoult C; Tron F; Gilbert D; Musette P
J Immunol; 2009 Nov; 183(10):6207-16. PubMed ID: 19841185
[TBL] [Abstract][Full Text] [Related]
15. Antinucleosome autoantibodies bind directly to cell lines in vitro and via the FcgammaRIIB receptor to B lymphocytes in vivo: a role for immune complexes in interactions between antinucleosome IgG2a and B cells of BXSB lupus mice.
Li X; Egorina E; Bertelsen EL; Dahlen H; Hannestad K
Scand J Immunol; 2004; 60(1-2):121-33. PubMed ID: 15238081
[TBL] [Abstract][Full Text] [Related]
16. B cell apoptosis accelerates the onset of murine lupus.
Trébéden-Nègre H; Weill B; Fournier C; Batteux F
Eur J Immunol; 2003 Jun; 33(6):1603-12. PubMed ID: 12778478
[TBL] [Abstract][Full Text] [Related]
17. IL-12-encoding plasmid has a beneficial effect on spontaneous autoimmune disease in MRL/MP-lpr/lpr mice.
Hagiwara E; Okubo T; Aoki I; Ohno S; Tsuji T; Ihata A; Ueda A; Shirai A; Okuda K; Miyazaki J; Ishigatsubo Y
Cytokine; 2000 Jul; 12(7):1035-41. PubMed ID: 10880249
[TBL] [Abstract][Full Text] [Related]
18. Treatment of autoimmune MRL/lpr mice with anti-B220 monoclonal antibody reduces the level of anti-DNA antibodies and lymphadenopathies.
Asensi V; Kimeno K; Kawamura I; Sakumoto M; Nomoto K
Immunology; 1989 Oct; 68(2):204-8. PubMed ID: 2478453
[TBL] [Abstract][Full Text] [Related]
19. Long term administration of cyclophosphamide in MRL/1 mice. I. The effects on the development of immunological abnormalities and lupus nephritis.
Shiraki M; Fujiwara M; Tomura S
Clin Exp Immunol; 1984 Feb; 55(2):333-9. PubMed ID: 6607792
[TBL] [Abstract][Full Text] [Related]
20. Fc receptor-independent development of autoimmune glomerulonephritis in lupus-prone MRL/lpr mice.
Matsumoto K; Watanabe N; Akikusa B; Kurasawa K; Matsumura R; Saito Y; Iwamoto I; Saito T
Arthritis Rheum; 2003 Feb; 48(2):486-94. PubMed ID: 12571859
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]